• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Epic Integrates with Genelex to Help Reduce Drug Complications

by HITC Staff 02/26/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Epic Integrates with Genelex to Help Reduce Drug Complications

Pharmacogenomic clinical analytics provider Genelex is integrating with EHR leader Epic to support the reduction of drug complications, hospitalizations and ED visits. The integration will enable Genelex customers using Epic to better identify patients who are at the highest risk of adverse drug events based on drug-gene and drug-drug gene interactions which has been proven to significantly lower ED visits and hospitalizations.

Genelex ‘s precision prescribing analytics software platform YouScript helps customers identify which patients are at the highest risk of adverse drug events, which ones would benefit from pharmacogenomic testing and what clinicians can do to optimize the safety and effectiveness of medications. Based on over 14,000 curated references and product inserts, YouScript determines the cumulative impact of genetics, medications, over-the-counters, herbals, and other factors offering ranked alternatives when interaction risk is found.

In a recently published study published in the Journal of Medical Economics, the University of Utah showed that the use of pharmacogenomic testing and YouScript’s clinical decision support software reduced hospitalizations by 39-percent and ER visits by 71-percent in elderly patients taking multiple medications in just 4-months.

“Think about us as a ‘precision medicine booster’ to enhance your traditional decision support tools,” says Genelex CEO Kristine Ashcraft in the release statement. “As many as 56% of all potentially clinically significant drug interactions are caused by drug-gene and cumulative drug-drug-gene or drug-drug-drug  interactions that can be missed by traditional decision support tools that check for drug-to-drug or drug-to allergy complications.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: epic emr, Epic Systems

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

 Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

CMS Finalizes New Interoperability and Prior Authorization Rule

CMS Proposes 2026 Physician Fee Schedule Rule: Boosting Primary Care, Cutting Waste, and Modernizing Payments

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

New Strategies Needed: No Surprises Act and the Challenges for Payors with Provider Data Inaccuracies

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

AI Dominates Digital Health Investment in First Half of 2025

Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |